These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7144066)

  • 1. Metoprolol in portal hypertension. A controlled study.
    Bützow GH; Remmecke J; Bräuer A
    Klin Wochenschr; 1982 Oct; 60(20):1311-4. PubMed ID: 7144066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.
    Hillon P; Lebrec D; Muńoz C; Jungers M; Goldfarb G; Benhamou JP
    Hepatology; 1982; 2(5):528-31. PubMed ID: 7118065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension.
    Westaby D; Bihari DJ; Gimson AE; Crossley IR; Williams R
    Gut; 1984 Feb; 25(2):121-4. PubMed ID: 6693039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.
    Gatta A; Sacerdoti D; Merkel C; Milani L; Battaglia G; Zuin R
    Am Heart J; 1984 Oct; 108(4 Pt 2):1167-72. PubMed ID: 6148880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis.
    Koshy A; Hadengue A; Lee SS; Jiron MI; Lebrec D
    Clin Pharmacol Ther; 1987 Sep; 42(3):295-8. PubMed ID: 3621783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension.
    Sekiyama T; Komeichi H; Nagano T; Ohsuga M; Terada H; Katsuta Y; Satomura K; Aramaki T
    Arzneimittelforschung; 1997 Apr; 47(4):353-5. PubMed ID: 9150854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].
    Lazebnik LB; Mikheeva OM; Toporkov AS; Komissarenko IA; Vasnev OS; Fedulenkova LV
    Eksp Klin Gastroenterol; 2007; (5):57-66. PubMed ID: 18389599
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
    Gatta A; Sacerdoti D; Merkel C; Rossoni R; Finucci G; Bolognesi M; Zuin R
    Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductions in portal pressure by selective beta 2-adrenoceptor blockade in patients with cirrhosis and portal hypertension.
    Bihari D; Westaby D; Gimson A; Crossley I; Harry J; Williams R
    Br J Clin Pharmacol; 1984 Jun; 17(6):753-7. PubMed ID: 6146330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis.
    Austin AS; Mahida YR; Clarke D; Ryder SD; Freeman JG
    Aliment Pharmacol Ther; 2004 Jan; 19(1):79-88. PubMed ID: 14687169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a serotonin S2 receptor antagonist on portal hypertension due to cirrhosis. Preliminary results of a heart and liver hemodynamic study].
    Deflandre J; Pirotte J; Etienne M; Carlier J
    Ann Gastroenterol Hepatol (Paris); 1988; 24(3):103-5. PubMed ID: 3400992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol in portal hypertension: problems in paradise?
    Conn HO
    Hepatology; 1984; 4(3):560-4. PubMed ID: 6609871
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic differences between metoprolol and carvedilol in hypertensive patients.
    Weber K; Bohmeke T; van der Does R; Taylor SH
    Am J Hypertens; 1998 May; 11(5):614-7. PubMed ID: 9633801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal-systemic encephalopathy and gastrointestinal bleeding after cardioselective beta-blocker (metoprolol) administration to patients with portal hypertension.
    Uribe M; Orozco H; Morán S; Guevara L; Poo JL; Vargas-Vorackova F
    Arch Med Res; 1995; 26(3):221-6. PubMed ID: 8580671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes.
    Bruha R; Vitek L; Petrtyl J; Lenicek M; Urbanek P; Zelenka J; Jachymova M; Svestka T; Kalab M; Dousa M; Marecek Z
    Scand J Gastroenterol; 2006 Dec; 41(12):1454-63. PubMed ID: 17101577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological mechanisms of the antihypertensive effect of a cardioselective beta-adrenoceptor blocking drug (metoprolol).
    Ljungman S; Hartford M; Aurell M; Berglund G
    Acta Med Scand Suppl; 1979; 625():31-5. PubMed ID: 285572
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
    Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
    Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.